Clinical trials
Phase 1 Blastic Plasmacytoid Dendritic Cell Neoplasm trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Completed | 4 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 2 |
| Dana-Farber Cancer Institute | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Cellectis S.A. | 1 |
| MacroGenics | 1 |
| Mayo Clinic | 1 |
| National Cancer Institute (NCI) | 1 |
| Orca Biosystems, Inc. | 1 |
| Senti Biosciences | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 15 |
| Leukemia, Myeloid, Acute | 9 |
| Leukemia, Biphenotypic, Acute | 6 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 |
| Myelodysplastic Syndromes | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Blast Crisis | 3 |
| Burkitt Lymphoma | 3 |
| Hematologic Neoplasms | 3 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.